Abstract:Peptide deformylase is an attractive target for developing novel antibiotics. Previous studies at pH 3.0 showed peptide deformylase from Leptospira interrogans (LiPDF) exists as a dimer in which one monomer is in a closed form and the other is in an open form, with different conformations of the CD-loop controlling the entrance to the active pocket. Here we present structures of LiPDF at its active pH range. LiPDF forms a similar dimer at pH values 6.5-8.0 as it does at pH 3.0. Interestingly, both of the monomers are almost in the same closed form as that observed at pH 3.0. However, when the enzyme is complexed with the natural inhibitor actinotin, the conformation of the CD-loop is half-open. Two pairs of Arg109-mediated cation-π interactions, as well as hydrogen bonds, have been identified to stabilize the different CD-loop conformations. These results indicate that LiPDF may be found in different structural states, a feature that has never before been observed in the peptide deformylase family. Based on our results, a novel substrate binding model, featured by an equilibrium between the closed and the open forms, is proposed. Our results present crystallographic evidence supporting population shift theory, which is distinguished from the conventional lock-and-key or induced-fit models. These results not only facilitate the development of peptide deformylase-targeted drugs but also provide structural insights into the mechanism of an unusual type of protein binding event.

Co-crystallization of Leptospira interrogans peptide deformylase with a potent inhibitor and molecular-replacement schemes with eight subunits in an asymmetric unit.

Unique structural characteristics of peptide deformylase from pathogenic bacterium Leptospira interrogans.

Novel Conformational States of Peptide Deformylase from Pathogenic Bacterium Leptospira Interrogans

Investigation of Zinc-Containing Peptide Deformylase from Leptospira Interrogans by X-Ray Absorption Near-Edge Spectroscopy

New peptide deformylase inhibitors design, synthesis and pharmacokinetic assessment

Toward More Selective Antibiotic Inhibitors: A Structural View of the Complexed Binding Pocket of E. coli Peptide Deformylase

Characterization of Peptide Deformylase Homologues from Staphylococcus Epidermidis

Crystallization and Preliminary X-ray Crystallographic Analysis of a Putative Nonribosomal Peptide Synthase AmbB from Pseudomonas Aeruginosa.

Crystallization and Preliminary Crystallographic Studies of Antibacterial Polypeptide LCI Expressed Inescherichia Coli

Peptide deformylase inhibitors of Mycobacterium tuberculosis: Synthesis, structural investigations, and biological results

Three-Dimensional Structures of Pathogenic and Saprophytic Leptospira Species Revealed by Cryo-Electron Tomography

2.8-Å Cryo-EM Structure of the Large Ribosomal Subunit from the Eukaryotic Parasite Leishmania.

3D-QSAR and Molecular Docking Studies of Hydroxamic Acids As Peptide Deformylase Inhibitors

Molecular insights into the dynamic modulation of bacterial ClpP function and oligomerization by peptidomimetic boronate compounds

Theoretical Study of the Catalytic Mechanism and Metal-Ion Dependence of Peptide Deformylase

H-Phosphonate Derivatives As Novel Peptide Deformylase Inhibitors

Expression, Characterisation, Homology Modelling and Molecular Docking of a Novel M17 Family Leucyl-Aminopeptidase from Bacillus cereus CZ

AlphaFold-assisted structure determination of a bacterial protein of unknown function using X-ray and electron crystallography

Lipidic cubic phase injector facilitates membrane protein serial femtosecond crystallography

Crystallization and preliminary crystallographic studies of human coactosin-like protein (CLP).

Crystallization and Preliminary Crystallographic Analysis of the Extracellular Fragment of FcalphaRI/CD89.